Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related diseases and disorders
US10968203B2 · kind B2 · utility
0Cited by
5References
41Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 24, 2018 |
| Grant date | Apr 6, 2021 |
| Priority date | — |
| Expiry date | May 24, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are pyrimidinyl-pyridyloxy-naphthyl compounds with inositol requiring enzyme 1 (IRE1) modulation activity or function having the Formula I or I′ structure:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.